Illimis Therapeutics
PrivateLast Round
Grant
Jul 15, 2025
Est. Valuation
$107.17M
Total Funding Raised
$59M
Company Overview
Illimis Therapeutics is a biotechnology company developing fusion protein-based therapeutics for the treatment of intractable diseases like Alzheimer's and other immune-related disorders.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Illimis Therapeutics Comps
Public and private peers based on sector, stage, and business model.
Illimis Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Jul 15, 2025 | ||||
| Series B | Jul 14, 2025 | ||||
| Series A | Apr 14, 2023 |
Key People
Founding team and executive leadership
Illimis Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Hana Ventures | Series B |
| DSC Investment | Series B |
| A Ventures | Series B |
| Shinhan Venture Investment | Series B |
| DAYLI Partners | Series B, Series A |
| TS Investment | Series B |
| GS Ventures | Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 15, 2025
$1.6M grant awarded
- Jul 14, 2025
$42M raised in Series B round.
Illimis Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Illimis Therapeutics's valuation, stock price, and market status.
